Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
Condition(s):Acute PorphyriasLast Updated:March 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Acute PorphyriasLast Updated:March 31, 2023Completed
Condition(s):Acute Intermittent PorphyriaLast Updated:March 12, 2014Completed
Condition(s):PorphyriasLast Updated:October 16, 2019Completed
Condition(s):Variegate PorphyriaLast Updated:January 25, 2024Completed
Condition(s):Acute Intermittent PorphyriaLast Updated:June 14, 2018Completed
Condition(s):Rare Diseases; PorphyriasLast Updated:September 1, 2022Active, not recruiting
Condition(s):Acute Porphyrias; Cutaneous PorphyriasLast Updated:March 6, 2024Recruiting
Condition(s):Acute Intermittent PorphyriaLast Updated:March 12, 2024Completed
Condition(s):Porphyria, Acute IntermittentLast Updated:February 22, 2024Recruiting
Condition(s):Acute Intermittent PorphyriaLast Updated:December 18, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.